Reporte de caso
Alopecia reversible secundaria a metilfenidato OROS
Reversible Alopecia Secondary to OROS Methylphenidate
Marta Núñez-Garces
, Agustín Sánchez-Gayango, Cristina Romero-Pérez
Autor para correspondencia
Unidad de Gestión Clínica de Salud Mental, Área de Gestión Sanitaria Sur de Sevilla, Hospital Universitario Nuestra Señora de Valme, Sevilla, España
Leído
6899
Vecesse ha leído el artículo
548
Total PDF
6351
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 25 | 5 | 30 |
| 2025 11 | 144 | 28 | 172 |
| 2025 10 | 186 | 10 | 196 |
| 2025 9 | 156 | 13 | 169 |
| 2025 8 | 134 | 8 | 142 |
| 2025 7 | 167 | 10 | 177 |
| 2025 6 | 168 | 10 | 178 |
| 2025 5 | 183 | 8 | 191 |
| 2025 4 | 159 | 8 | 167 |
| 2025 3 | 182 | 9 | 191 |
| 2025 2 | 177 | 8 | 185 |
| 2025 1 | 196 | 1 | 197 |
| 2024 12 | 142 | 4 | 146 |
| 2024 11 | 162 | 7 | 169 |
| 2024 10 | 172 | 3 | 175 |
| 2024 9 | 168 | 10 | 178 |
| 2024 8 | 174 | 3 | 177 |
| 2024 7 | 127 | 7 | 134 |
| 2024 6 | 112 | 4 | 116 |
| 2024 5 | 92 | 4 | 96 |
| 2024 4 | 112 | 6 | 118 |
| 2024 3 | 121 | 2 | 123 |
| 2024 2 | 86 | 3 | 89 |
| 2024 1 | 94 | 4 | 98 |
| 2023 12 | 119 | 16 | 135 |
| 2023 11 | 129 | 14 | 143 |
| 2023 10 | 129 | 17 | 146 |
| 2023 9 | 83 | 21 | 104 |
| 2023 8 | 101 | 13 | 114 |
| 2023 7 | 113 | 25 | 138 |
| 2023 6 | 107 | 20 | 127 |
| 2023 5 | 149 | 25 | 174 |
| 2023 4 | 107 | 12 | 119 |
| 2023 3 | 110 | 18 | 128 |
| 2023 2 | 90 | 17 | 107 |
| 2022 1 | 76 | 5 | 81 |
| 2022 12 | 75 | 13 | 88 |
| 2022 11 | 78 | 9 | 87 |
| 2022 10 | 61 | 7 | 68 |
| 2022 9 | 82 | 9 | 91 |
| 2022 8 | 118 | 9 | 127 |
| 2022 7 | 115 | 12 | 127 |
| 2022 6 | 82 | 6 | 88 |
| 2022 5 | 80 | 10 | 90 |
| 2022 4 | 165 | 9 | 174 |
| 2022 3 | 115 | 11 | 126 |
| 2022 2 | 100 | 5 | 105 |
| 2021 1 | 98 | 13 | 111 |
| 2021 12 | 88 | 15 | 103 |
| 2021 11 | 72 | 12 | 84 |
| 2021 10 | 84 | 11 | 95 |
| 2021 9 | 75 | 4 | 79 |
| 2021 8 | 71 | 6 | 77 |
| 2021 7 | 40 | 9 | 49 |
Mostrar todo
